Carnitine, Aclycarnitine, Myocardial Function, and CRRT
NCT01941823 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2020-01-23
Summary
Carnitine is essential for the transport of fatty acids into the mitochondria and energy production in different muscles, including the myocardium. It is also needed to protect myocyte cell membranes from oxidative damage by removing excess acyl carnitine groups. Patients receiving chronic intermittent hemodialysis (HD) are known to be at increased risk for carnitine deficiency as a result of its removal during the dialysis procedure, lack of endogenous synthesis by the kidney, and inadequate dietary intake. The carnitine status of children undergoing continuous renal replacement therapy (CRRT) has not been studied. Children undergoing CRRT in the intensive care unit (ICU) setting may be at increased risk for carnitine deficiency due to its continuous removal, lack of carnitine production by the kidney, and absence of carnitine intake (as majority of these children can not eat and there is no carnitine added to total parenteral nutrition (TPN). Carnitine deficiency may increase the risk of cardiac dysfunction in critically ill children. This is the first study to examine carnitine status in children undergoing CRRT. Standard echo as well as more sensitive speckle tracking echo will be used to evaluate the effect of carnitine deficiency on myocardial function.
Conditions
- Acute Renal Failure
Sponsors & Collaborators
-
Asha Moudgil
lead OTHER
Principal Investigators
-
Asha Moudgil, MD · Children's National Research Institute
Eligibility
- Min Age
- 1 Year
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2019-10-31
- Completion
- 2019-10-31
Countries
- United States
Study Locations
More Related Trials
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
Citrate Pharmacokinetics and Regional Citrate Anticoagulation in CRRT
NCT00948558 ·Status: UNKNOWN
-
Effects of Carnitine on Oxidative Stress to IVIR Administration to CKD Patients:Impact of Haptoglobin Genotype
NCT02312414 ·Status: UNKNOWN ·Phase: NA
-
Acute Renal Failure Post Liver Transplantation
NCT01907061 ·Status: COMPLETED ·Phase: NA
-
Arginase Inhibition in Ischemia-reperfusion Injury
NCT02009527 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients
NCT00161369 ·Status: COMPLETED
-
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
NCT03982160 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass
NCT00187330 ·Status: COMPLETED ·Phase: PHASE2
-
Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury
NCT03236441 ·Status: COMPLETED ·Phase: NA
-
Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy.
NCT03867994 ·Status: COMPLETED ·Phase: PHASE2
-
Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
NCT04163484 ·Status: COMPLETED
-
Early Hydration in Acute Myocardial Infarction
NCT01742130 ·Status: COMPLETED ·Phase: PHASE4
-
Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery
NCT00211653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Role of Acetylcysteine in Creatinine Clearance
NCT00396396 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
NCT00930436 ·Status: TERMINATED ·Phase: PHASE3
-
Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery
NCT06521307 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury
NCT01612013 ·Status: COMPLETED ·Phase: NA
-
N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement
NCT01704482 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
NCT02468401 ·Status: COMPLETED ·Phase: NA
-
N-acetylcysteine to Prevent Renal Failure
NCT01359722 ·Status: UNKNOWN ·Phase: NA
-
Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
NCT02791906 ·Status: TERMINATED ·Phase: PHASE2
-
Renal Acute MI Study
NCT01580566 ·Status: COMPLETED
-
Using Preprocedural Urine NMR(Nuclear Magnetic Resonance) -Based Metabolomics Analysis
NCT03731962 ·Status: COMPLETED ·Phase: NA
-
Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
NCT01218178 ·Status: COMPLETED
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3